KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Amortization of Deferred ChargesAmortizatization of IntangiblesCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in CashChange in ReceivablesDeferred TaxesDepreciation & Amortization (CF)Free Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeOther Working Capital ChangesOther financing activitiesShare-based CompensationShares Issued
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Oscar Health (OSCR) Cash from Investing Activities (2020 - 2025)

Oscar Health (OSCR) has disclosed Cash from Investing Activities for 6 consecutive years, with $150.1 million as the latest value for Q3 2025.

  • For the quarter ending Q3 2025, Cash from Investing Activities rose 125.98% year-over-year to $150.1 million, compared with a TTM value of -$223.8 million through Sep 2025, up 81.09%, and an annual FY2024 reading of -$1.4 billion, down 340.38% over the prior year.
  • Cash from Investing Activities was $150.1 million for Q3 2025 at Oscar Health, up from -$168.2 million in the prior quarter.
  • Across five years, Cash from Investing Activities topped out at $298.8 million in Q3 2022 and bottomed at -$708.0 million in Q2 2021.
  • Average Cash from Investing Activities over 5 years is -$105.5 million, with a median of -$19.8 million recorded in 2021.
  • Peak annual rise in Cash from Investing Activities hit 2516.48% in 2022, while the deepest fall reached 3462.43% in 2022.
  • Year by year, Cash from Investing Activities stood at -$19.8 million in 2021, then tumbled by 3462.43% to -$706.7 million in 2022, then skyrocketed by 124.41% to $172.5 million in 2023, then plummeted by 118.23% to -$31.4 million in 2024, then soared by 577.24% to $150.1 million in 2025.
  • Business Quant data shows Cash from Investing Activities for OSCR at $150.1 million in Q3 2025, -$168.2 million in Q2 2025, and -$174.2 million in Q1 2025.